NO995389L - COX-2 selective carprofen for the treatment of pain and inflammation in dogs - Google Patents
COX-2 selective carprofen for the treatment of pain and inflammation in dogsInfo
- Publication number
- NO995389L NO995389L NO995389A NO995389A NO995389L NO 995389 L NO995389 L NO 995389L NO 995389 A NO995389 A NO 995389A NO 995389 A NO995389 A NO 995389A NO 995389 L NO995389 L NO 995389L
- Authority
- NO
- Norway
- Prior art keywords
- carprofen
- cox
- dogs
- inflammation
- pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4563597P | 1997-05-05 | 1997-05-05 | |
PCT/IB1998/000662 WO1998050033A1 (en) | 1997-05-05 | 1998-05-01 | Cox-2 selective carprofen for treating pain and inflammation in dogs |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995389D0 NO995389D0 (en) | 1999-11-04 |
NO995389L true NO995389L (en) | 2000-01-04 |
Family
ID=21939053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO995389A NO995389L (en) | 1997-05-05 | 1999-11-04 | COX-2 selective carprofen for the treatment of pain and inflammation in dogs |
Country Status (32)
Country | Link |
---|---|
EP (1) | EP0988034A1 (en) |
JP (1) | JP2000513020A (en) |
KR (2) | KR20040004406A (en) |
CN (1) | CN1255059A (en) |
AP (1) | AP9801234A0 (en) |
AR (2) | AR011726A1 (en) |
AU (1) | AU6932198A (en) |
BG (1) | BG103852A (en) |
BR (1) | BR9808720A (en) |
CA (1) | CA2288759A1 (en) |
DZ (1) | DZ2479A1 (en) |
EA (1) | EA003696B1 (en) |
GT (1) | GT199800063A (en) |
HR (1) | HRP980244A2 (en) |
HU (1) | HUP0001286A3 (en) |
ID (1) | ID21311A (en) |
IL (1) | IL132570A0 (en) |
IS (1) | IS5220A (en) |
MA (1) | MA26491A1 (en) |
NO (1) | NO995389L (en) |
NZ (1) | NZ500183A (en) |
OA (1) | OA11213A (en) |
PA (1) | PA8450601A1 (en) |
PE (1) | PE72599A1 (en) |
PL (1) | PL337003A1 (en) |
SK (1) | SK148199A3 (en) |
TN (1) | TNSN98059A1 (en) |
TW (1) | TW590773B (en) |
UY (1) | UY24989A1 (en) |
WO (1) | WO1998050033A1 (en) |
YU (1) | YU55899A (en) |
ZA (1) | ZA983722B (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
AU2003204888B2 (en) * | 1998-05-22 | 2005-07-28 | Pfizer Products Inc. | Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives |
US6506785B2 (en) * | 1998-05-22 | 2003-01-14 | Pfizer, Inc. | Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
CA2347365A1 (en) * | 1998-10-23 | 2000-05-04 | Merck Frosst Canada & Co. | Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
EP1637137A3 (en) * | 1999-03-10 | 2006-07-05 | G.D. Searle LLC | Method and composition for administering a cyclooxygenase-2 inhibitor to animals |
AU1592901A (en) * | 1999-11-11 | 2001-06-06 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
JP2004521856A (en) * | 2000-05-15 | 2004-07-22 | メルク フロスト カナダ アンド カンパニー | Combination therapy using a COX-2 selective inhibitor and a thromboxane inhibitor and compositions therefor |
BR0111767A (en) | 2000-06-13 | 2003-07-08 | Wyeth Corp | Analgesic and anti-inflammatory compositions containing cox-2 inhibitors, their use and method for enhancing an analgesic compound |
DE10032132A1 (en) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition |
AU2001284753B2 (en) | 2000-08-07 | 2006-10-26 | Vanderbilt University | Detection of COX-2 activity and anandamide metabolites |
WO2003007875A2 (en) * | 2001-07-16 | 2003-01-30 | Hoegestaett Edward | Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
JP4354984B2 (en) | 2003-05-07 | 2009-10-28 | オステオロジックス エイ/エス | Treatment of cartilage / bone symptoms with water-soluble strontium salts |
JP2007500691A (en) * | 2003-07-31 | 2007-01-18 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Dispersible formulation of anti-inflammatory agent |
CA2608010A1 (en) * | 2005-05-20 | 2006-11-23 | Pfizer Limited | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands |
PT2079456E (en) | 2007-04-04 | 2013-03-13 | Sigmoid Pharma Ltd | Pharmaceutical cyclosporin compositions |
WO2008132707A1 (en) | 2007-04-26 | 2008-11-06 | Sigmoid Pharma Limited | Manufacture of multiple minicapsules |
BRPI1012196B1 (en) | 2009-05-18 | 2021-11-30 | Sublimity Therapeutics Limited | COMPOSITION INCLUDING OIL DROPS |
GB2485327A (en) | 2009-08-12 | 2012-05-09 | Sigmoid Pharma Ltd | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
CN105939713A (en) * | 2014-03-06 | 2016-09-14 | 阿莱塔纳治疗学股份有限公司 | Compositions of grapiprant and methods for using same |
CN107106644B (en) | 2014-11-07 | 2022-04-15 | 卓越治疗有限公司 | Cyclosporin-containing compositions |
EP3242557A4 (en) * | 2015-01-09 | 2018-09-05 | Jaguar Health, Inc. | Methods of treating diarrhea in companion animals |
EP4125874A4 (en) * | 2020-03-25 | 2024-05-01 | Stanford Res Inst Int | Lipoxygenase inhibitors |
US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
KR102404883B1 (en) | 2020-11-30 | 2022-06-07 | (주)이노보테라퓨틱스 | Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
-
1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/en active
- 1998-04-30 TW TW087106689A patent/TW590773B/en not_active IP Right Cessation
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/en not_active IP Right Cessation
- 1998-05-01 IL IL13257098A patent/IL132570A0/en unknown
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 CN CN98804845A patent/CN1255059A/en active Pending
- 1998-05-01 PL PL98337003A patent/PL337003A1/en unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/en unknown
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/en not_active Application Discontinuation
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/en unknown
- 1998-05-01 JP JP10547869A patent/JP2000513020A/en active Pending
- 1998-05-01 SK SK1481-99A patent/SK148199A3/en unknown
- 1998-05-01 YU YU55899A patent/YU55899A/en unknown
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Application Discontinuation
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/en not_active Application Discontinuation
- 1998-05-01 EA EA199900895A patent/EA003696B1/en not_active IP Right Cessation
- 1998-05-04 UY UY24989A patent/UY24989A1/en not_active Application Discontinuation
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/en unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/en not_active Application Discontinuation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/en unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/en unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/en unknown
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/en unknown
- 1998-05-05 AR ARP980102089A patent/AR011726A1/en unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/en not_active Application Discontinuation
-
1999
- 1999-10-19 IS IS5220A patent/IS5220A/en unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/en unknown
- 1999-11-04 NO NO995389A patent/NO995389L/en not_active Application Discontinuation
-
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995389L (en) | COX-2 selective carprofen for the treatment of pain and inflammation in dogs | |
NO20005190L (en) | Therapeutic angiogenic factors and methods for their use | |
NO20014560D0 (en) | Quinasolines and their therapeutic use | |
DE69825447D1 (en) | DERMATOLOGICAL TREATMENT DEVICE | |
IS5405A (en) | Prostaglandin agonists and their use in the treatment of bone disorders | |
ID18741A (en) | Nicotinic Substance in Therapy | |
DE69630947D1 (en) | PAIN TREATMENT AGENTS | |
NO20022656L (en) | Caspase Inhibitors and Their Use | |
EE05073B1 (en) | Retigabine for use in the treatment of neuropathic pain | |
DE69805438T2 (en) | MIXING AND CHARGING OPENING FOR MEDICAL TREATMENT | |
NO983576L (en) | Well treatment fluids and methods | |
NO20005179D0 (en) | Drug treatment | |
DE69701250D1 (en) | Animal treatment device | |
ID24060A (en) | IMPROVED ANIMAL SKIN TREATMENT | |
NO20012738D0 (en) | Therapeutic products and their use | |
IT1318619B1 (en) | PROCEDURE AND ELECTROCHEMICAL TREATMENT DEVICE. | |
PT1178981E (en) | SUBSTITUTED 3-PYRIDYL-4-ARYLIPYROLS AND THERAPEUTIC AND PROFILACTIC METHODS | |
DK0915655T3 (en) | Method and composition for the treatment of parasites in animal environments | |
AU5388299A (en) | Antibodies for use in targeted and temporary treatment of humans and animals | |
DE69932577D1 (en) | Bar treatment device and bar charger | |
ID30458A (en) | OSANETAN IN TREATMENT OF SOUL DISORDERS | |
IS6428A (en) | Method and mix to treat pain | |
NO992561D0 (en) | Slurry treatment system and slurry treatment method | |
DE29801793U1 (en) | Therapy and treatment device | |
IS6427A (en) | Compound and method of treating pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |